A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

The system contains a sensor, chip and tiny AI model inspired by biological eyes and brains and uses a tenth of the energy of a camera-based system.